Evidence map›Paper›PMID 32651375›Full record

ArticleNature communications2020

Structure of the DOCK2-ELMO1 complex provides insights into regulation of the auto-inhibited state.

Leifu Chang, Jing Yang, Chang Hwa Jo, Andreas Boland, Ziguo Zhang, Stephen H McLaughlin, Afnan Abu-Thuraia, Ryan C Killoran, Matthew J Smith, Jean-Francois Côté and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Structural basis for membrane-dependent positive feedback regulation of DOCK11 by activated Cdc42.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Targeting of ELMO2 by thebioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Heterozygous variants in DOCK2 leading to susceptibility to viral illnesses.The Journal of allergy and clinical immunology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genes · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Leifu ChangMRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.
Jing YangMRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.
Chang Hwa JoInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, H3T 1J4, Canada.ORCID http://orcid.org/0000-0002-7819-8307
Andreas BolandMRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.ORCID http://orcid.org/0000-0003-1218-6714
Ziguo ZhangMRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.ORCID http://orcid.org/0000-0002-7268-9631
Stephen H McLaughlinMRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.ORCID http://orcid.org/0000-0001-9135-6253
Afnan Abu-ThuraiaMontreal Institute of Clinical Research (IRCM), Montréal, QC, H2W 1R7, Canada.ORCID http://orcid.org/0000-0002-7848-3327
Ryan C KilloranInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, H3T 1J4, Canada.
Matthew J Smith *Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, H3T 1J4, Canada.ORCID http://orcid.org/0000-0003-2896-9350
Jean-Francois Côté *Montreal Institute of Clinical Research (IRCM), Montréal, QC, H2W 1R7, Canada.ORCID http://orcid.org/0000-0001-7055-2642
David BarfordMRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK. dbarford@mrc-lmb.cam.ac.uk.ORCID http://orcid.org/0000-0001-8810-950X
MRC Laboratory of Molecular Biology · GBInstitute for Research in Immunology and Cancer · CAMontreal Clinical Research Institute · CAUniversity of Geneva · CH

Funding

Biotechnology and Biological Sciences Research CouncilCancer Research UK 14109Cancer Research UK 24307Cancer Research UK C576/A14109Medical Research Council MC_UP_1201/6Wellcome Trust
6 · The paper itself

Abstract

DOCK (dedicator of cytokinesis) proteins are multidomain guanine nucleotide exchange factors (GEFs) for RHO GTPases that regulate intracellular actin dynamics. DOCK proteins share catalytic (DOCK

Indexed as

Adaptor Proteins, Signal TransducingCalorimetryGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsHEK293 CellsHeLa CellsHumansImmunoblottingKineticsMicroscopy, ElectronPhosphorylationrac1 GTP-Binding Proteinrho GTP-Binding ProteinsAdaptor Proteins, Signal TransducingDOCK2 protein, humanELMO1 protein, humanGTPase-Activating ProteinsGuanine Nucleotide Exchange Factorsrac1 GTP-Binding ProteinRHOG protein, humanrho GTP-Binding Proteins

Identifiers

PMID32651375
PMCPMC7351999
OpenAlexW3041891313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.